Clinical Trial: UAB Recessive PKD Research and Translational Core Center

Study Status: Completed
Recruit Status: Unknown status
Study Type: Observational



Official Title: The ARPKD Clinical and Genetic Resource (UAB Recessive PKD Research and Translational Core Center)

Brief Summary:

The University of Alabama at Birmingham Recessive Polycystic Kidney Disease Core Center (UAB RPKDCC) has established a NIDDK-funded, interdisciplinary center of excellence in PKD-related research, with specific emphasis on recessive PKD. Among the five Cores, the UAB RPKDCC includes the ARPKD Clinical and Genetic Resource, a Core resource designed to develop a unique set of clinical, genetic, and educational resources for ARPKD. The Core has three primary objectives:

  1. To extend the observational study of ARPKD initiated by the North American ARPKD Database.
  2. To provide a mechanism for genetic evaluation of patients with both classic ARPKD and unusual phenotypes of recessive PKD.
  3. To develop educational tools for physicians and patients regarding the natural history, cause, development and effects of the disease, genetic testing, and clinical trials applicable to ARPKD.